Life sciences news
-
Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON
Tuesday November 15th 2022
Read more
-
UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients
Monday November 14th 2022
Read more
-
Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors
Friday November 11th 2022
Read more
-
Is Belgium becoming a hub for gene therapy?
Thursday November 10th 2022
Read more
-
The QbD Group acquires regulatory affairs and pharmacovigilance company EUDRAC Ltd to expand its services for pharmaceutical customers
Tuesday November 8th 2022
Read more
-
New Idylla™ EGFR study shows reduction of time-to-treatment by 48% for lung cancer patients
Tuesday November 8th 2022
Read more
-
BIO INX and Nanoscribe expand their partnership with the launch of HYDROBIO INX© N400, a new biocompatible high resolution bioink enabling live cell encapsulation
Tuesday November 8th 2022
Read more
-
How did human brains get so large?
Friday November 4th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Friday November 4th 2022
Read more
-
InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model
Friday October 28th 2022
Read more
-
Indigo Diabetes incorporates fully owned subsidiary in the US and appoints Peter J. Devlin as President, Indigo Medical US Inc.
Thursday October 27th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
